Mice Model Technologies Market to Grow with a CAGR of 10.23% through 2029

Increasing utilization of mice models for personalized drug production are expected to drive the Global Mice Model Technologies Market growth in the forecast period, 2025-2029

According to TechSci Research report, “Mice Model Technologies Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029”, the Global Mice Model Technologies Market stood at USD 1.22 Billion in 2023 and is anticipated to grow with a CAGR of 10.23% through 2029. The global market for mice model technologies is poised for rapid expansion in the forecast period, primarily due to the increasing adoption of mice models in personalized drug production. Additionally, heightened investments in research and development within the pharmaceutical and biotechnology sectors are anticipated to further bolster market growth. The growing utilization of mice models in monoclonal antibody production is also expected to contribute significantly to market expansion.

However, the continuous exploration and discovery of alternative approaches for animal studies may act as a restraint on the growth of the global mice model technologies market during the forecast period. Notably, in March 2021, Charles River Laboratories International, Inc. announced its acquisition of Cognate BioServices, Inc., a leading contract development and manufacturing organization specializing in cell and gene therapy. This strategic move is aimed at expanding Charles River Laboratories' offerings and capabilities in the field of cell and gene therapy.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Mice Model Technologies Market”

Mice models are essential assets in drug development and safety assessment studies, serving as indispensable tools for pharmaceutical firms. These models are extensively employed to evaluate the efficacy and safety of potential drug candidates before advancing them to clinical trials. Through the utilization of a diverse range of mice models that closely mimic human physiology, pharmaceutical companies can scrutinize critical factors such as drug metabolism, pharmacokinetics, and potential side effects. This comprehensive evaluation process ultimately leads to the enhancement of drug safety profiles, reduction in attrition rates during clinical trials, and optimization of the overall drug development workflow.

The integration of state-of-the-art imaging technologies and phenotyping methodologies has greatly amplified the research capabilities of mice models. By incorporating advanced imaging techniques such as magnetic resonance imaging (MRI), positron emission tomography (PET), and bioluminescence imaging, researchers can non-invasively monitor disease progression and treatment outcomes in live mice. Additionally, sophisticated phenotyping platforms capture a wealth of physiological, behavioral, and molecular data, providing comprehensive insights into disease characteristics and responses to therapeutic interventions. This amalgamation of advanced tools not only enhances the accuracy and productivity of research but also deepens our understanding of disease mechanisms and potential treatment approaches.

The Global Mice Model Technologies Market is segmented into Technology, End User, Region and company.

Based on the End Users segment, Biotechnology companies wield substantial influence within the Global Mice Model Technologies Market, serving as primary drivers of its expansion. Their pivotal involvement in drug discovery, development, and the quest for innovative therapies positions them to shape market growth significantly. By utilizing mice models in preclinical research, these firms capitalize on their versatility in mimicking human diseases and assessing novel treatments. Mice models are indispensable assets for biotech companies, enabling thorough evaluations of drug efficacy and safety, exploration of disease mechanisms, and advancement of personalized medicine research. As the industry increasingly embraces precision medicine, biotech firms seek customized mice models tailored to specific genetic conditions, facilitating the development of targeted therapeutics. The demand for genetically engineered mice intensifies as biotech companies vie for a competitive advantage in a dynamic market landscape. Strategic investments in mice model technologies, including cutting-edge advancements like CRISPR-Cas9, underscore their pivotal role in expediting research efforts and fostering innovation across the biotechnology sector.

Based on Region, The Asia-Pacific region is positioned to experience rapid growth within the Global Mice Model Technologies Market, driven by various contributing factors. One significant driver is the region's expanding pharmaceutical and biotechnology sector, fueled by increased investments in research and development (R&D), governmental initiatives promoting innovation, and a growing emphasis on improving healthcare infrastructure. Consequently, there is a heightened demand for mice models in preclinical research and drug development endeavors throughout the Asia-Pacific region. The region is undergoing a notable demographic transition characterized by an aging population and a rising prevalence of chronic diseases. This shift underscores the need for new therapeutic solutions, driving the demand for advanced research tools like mice models to accelerate drug discovery and personalized medicine initiatives. Additionally, the presence of emerging economies such as China, India, and South Korea further drives market growth, spurred by rapid industrialization, urbanization, and a burgeoning number of biotechnology startups.

Moreover, the Asia-Pacific region offers cost advantages in terms of labor and operational expenses compared to developed economies, making it an attractive destination for outsourcing preclinical research activities. This trend contributes to market expansion as pharmaceutical companies and contract research organizations (CROs) increasingly collaborate with research institutions and mice model suppliers within the region.

Major companies operating in Global Mice Model Technologies Market are:

• Biocytogen LLC
• Charles River Laboratories Inc.
• Cyagen Biosciences
• GemPharmatech Co Ltd.
• genOway S.A.
• Ingenious Targeting Laboratory Inc.
• Merck KGaA.
• Ozgene Pty Ltd.
• Taconic Biosciences Inc.
• Polygena AG

Download Free Sample Report

Customers can also request 10% free customization on this report

“The market prospects have been driven by factors such as technological advancements over the analysis period. Advancements in technology have made it easier to manipulate the genes of mice models and create specific genetic modifications that mimic human diseases. This has opened up new avenues for research and drug development. The development of new techniques such as CRISPR/Cas9 gene editing has made it easier to create more precise and accurate mice models, which has further increased their utility in research.” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

“Mice Model Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (CRISPR Knockout, Random Insertions, Large and Targeted Insertions, ES Cell Modification (Homologous Recombination), Others), By End Users (Pharmaceutical Companies, Biotechnology Companies, Academic and Research Facilities, Contract Research And Manufacturing Organizations), By Region, By Competition 2019-2029F”, has evaluated the future growth potential of Global Mice Model Technologies Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Mice Model Technologies Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com